Damien Moran, industry account manager for pharmaceutical & biotechnology, Bürkert Fluid Control Systems, shares how to reduce fluid control and automation complexity in pharma process development.
Paul Barr, senior chemistry consultant at testing and regulatory specialist Broughton, outlines why a unified approach is essential and increasingly expected.
Jordan Smith marketing & sales operations coordinator, ScreenerKing explains why particle screening is a hidden quality-control step in pharmaceutical powder processing.
Patrick Bilbo, COO, Organogenesis, explores the factors driving need for wound care – such as the ageing population, increasing rate of obesity and diabetes, sports and military injuries.
Chris Allen, CEO of contract research organisation Broughton, explains the critical role of laboratory information management systems (LIMS) in supporting these requirements.
Sherma Ellis Daal, brand director –Pharma, Informa Markets, explores how Asia-Pacific is evolving from a low-cost manufacturing base into a global innovation hub, with Singapore leading in advanced pharma capabilities, AI, and next-gen drug delivery.
Ywan Karlen, general manager EMEA, Ascentium Talent looks at why compliance-first AI training is the only kind European pharma will trust in 2026 — and what that means for L&D procurement.
Steve Ennis, manufacturing sector manager for Aggreko, explores the potential for battery energy storage systems (BESS) to become the industry’s safety net, looking at how it can address the issues of grid shortages and spiking energy costs.
Beccy Bell, operations director at testing and regulatory specialist Broughton, examines how stability study management shifts as data moves beyond contained documentation and begins to inform decisions for products already on the market.
Ray Niemeyer, vice president of sales at SpaceGuard Products explains the importance of durable guarding and rack protection systems in cold storage and cleanroom environments.
Matt Cokely, global technical consultant director at Ecolab explores how rapid recovery in a GMP environment means restoring control through predefined, risk-based and inspection-defensible strategies that protect sterility assurance under pressure.
